To assess the clinical response variability among different patient groups in RA patients under MTX treatment, a study involving twenty-three SNPs in SLC and ABC MTX transporters evaluated the influence of these SNPs as important predictors to MTX in Portuguese RA patients. This evidence concerns the gene CCL21 and rheumatoid arthritis.